Cloruro de metiltioninio Proveblue 5 mg/ml solución inyectable – Ficha técnica (SmPC) (2011)

Government Record · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA database; holder Provepharm · 2011

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), 2011: Spanish AEMPS product information for Cloruro de metiltioninio Proveblue 5 mg/mL injection, authorised for acute symptomatic treatment of drug- and chemical-induced methaemoglobinaemia in patients aged 0-17 and adults, dosed 1-2 mg/kg with a 7 mg/kg cumulative maximum.

Tratamiento sintomático agudo de la metahemoglobinemia inducida por medicamentos y sustancias químicas.

1

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), 2011: Spanish AEMPS product information for Cloruro de metiltioninio Proveblue 5 mg/mL injection, authorised for acute symptomatic treatment of drug- and chemical-induced methaemoglobinaemia in patients aged 0-17 and adults, dosed 1-2 mg/kg with a 7 mg/kg cumulative maximum. C7 Spain – approval record. AEMPS registry number 111682002; holder Provepharm; marketed in Spain by Fresenius Kabi España, S.A.U.; hospital-use prescription medicine. Indication as quoted; dose 1-2 mg/kg (0.2-0.4 mL/kg) over 5 minutes, repeatable after one hour, maximum cumulative 7 mg/kg. Searching the CIMA database for 'azul de metileno' returns zero records – the authorised product is indexed under the INN 'metiltioninio'. Spanish-language quote. The HTML doctype page cited as source_url is the AEMPS rendering of the same document supplied as the PDF. NOTE ON QUOTE CHECK: the AEMPS HTML rendering carries Spanish accents as numeric entities (á etc.), so the quote matches only after HTML unescaping; the same sentence is verified verbatim in the PDF (pdf_url). Study type: regulatory record.